Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-25-002279
Filing Date
2025-04-17
Accepted
2025-04-17 08:30:52
Documents
3
Period of Report
2025-04-17

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k_041725.htm 6-K 6623
2 PRESS RELEASE exh_991.htm EX-99.1 21906
3 EXHIBIT 99.2 exh_992.htm EX-99.2 62161
  Complete submission text file 0001171843-25-002279.txt   91853
Mailing Address 1 CASPIAN POINT CASPIAN WAY CARDIFF X0 CF10 4DQ
Business Address 1 CASPIAN POINT CASPIAN WAY CARDIFF X0 CF10 4DQ 44 (0)1235 888300
Biodexa Pharmaceuticals Plc (Filer) CIK: 0001643918 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37652 | Film No.: 25844381
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)